Literature DB >> 11501497

Detection of the retinoic acid-regulated genes in a RTBM1 neuroblastoma cell line using cDNA microarray.

K Ueda1.   

Abstract

A microarray system is a powerful and very useful technology for analyzing the expression profile of thousands of genes. In this study, we made a cDNA microarray system carrying 2007 cDNAs obtained from primary neuroblastoma cDNA library and identified retinoic acid (RA)-regulated genes in a RTBM1 neuroblastoma cell line. We repeated independent hybridization experiment twice and found that 7 genes were up-regulated, and 5 genes were down-regulated on the cDNA microarray. The semi-quantitative reverse transcriptase (RT)-PCR analysis to confirm the results showed that 4 genes which included amyloid precursor-like protein 2 (APLP2), P311, dihydropyrimidinase related protein3 (DRP3) and RGP4 were up-regulated, while 2 genes, Id-2 and vimentin, were down-regulated. Thus, our neuroblastoma cDNA microarray system is useful to screen the neuronal differentiation- and growth-related genes regulated by RA with high efficiency.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11501497     DOI: 10.2739/kurumemedj.48.159

Source DB:  PubMed          Journal:  Kurume Med J        ISSN: 0023-5679


  3 in total

1.  Identification of phosphoproteins as possible differentiation markers in all-trans-retinoic acid-treated neuroblastoma cells.

Authors:  Giorgia Mandili; Cristina Marini; Franco Carta; Cristina Zanini; Mauro Prato; Amina Khadjavi; Franco Turrini; Giuliana Giribaldi
Journal:  PLoS One       Date:  2011-05-05       Impact factor: 3.240

Review 2.  Are gene expression microarray analyses reliable? A review of studies of retinoic acid responsive genes.

Authors:  Peter J van der Spek; Andreas Kremer; Lynn Murry; Michael G Walker
Journal:  Genomics Proteomics Bioinformatics       Date:  2003-02       Impact factor: 7.691

Review 3.  P311, Friend, or Foe of Tissue Fibrosis?

Authors:  Leslie Stradiot; Inge Mannaerts; Leo A van Grunsven
Journal:  Front Pharmacol       Date:  2018-10-12       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.